A version of Eli Lilly’s Mounjaro is in short supply amid ongoing demand for the popular diabetes drug that is sometimes prescribed off-label for weight loss.
According to the FDA’s drug shortage list, there is a shortage of Mounjaro’s 10 mg dosage amount due to “intermittent backorders” likely expected to last through September. The 7.5 mg, 12.5 mg and 15 mg doses are also in short supply at least until the end of July. Past supply issues for the 2.5 mg and 5 mg doses have since been resolved.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters